Serum Α-Chlorofatty Acid as a Biomarker for Baseline Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar3956
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Estrogen in Cardiovascular Disease During Systemic Lupus Erythematosus

Clinical Therapeutics
Pharmacology
2014English

Mannose Binding Lectin: A Biomarker of Systemic Lupus Erythematosus Disease Activity

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2012English

Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis

Journal of Immunology Research
MedicineAllergyImmunology
2017English

Management of Cardiovascular Complications in Systemic Lupus Erythematosus

International Journal of Clinical Rheumatology
Rheumatology
2010English

Alpha-Chlorofatty Acid and Coronary Artery or Aorta Calcium Scores in Women With Systemic Lupus Erythematosus. A Pilot Study

Journal of Rheumatology
RheumatologyAllergyImmunology
2014English

A Study on Cardiovascular Manifestations of Systemic Lupus Erythematosus

Journal of Evolution of Medical and Dental Sciences
2017English

QRISK3 Improves Detection of Cardiovascular Disease Risk in Patients With Systemic Lupus Erythematosus

Lupus Science and Medicine
MedicineImmunology
2018English

Clinical Significance of Serum Sialic Acid in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Journal of UOEH
MedicineEnvironmentalPublic HealthOccupational Health
1985English

AB1125 Urinary Soluble Cd25 as a Biomarker of Active Lupus Nephritis in Egyptian Children With Juvenile Systemic Lupus Erythematosus

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy